Robert Essner | Amicus Therapeutics Board of Directors
Robert Essner

Robert Essner


Robert Essner has served as a member of the Board since June 2012. He also serves as a member of the Board of Directors of Organon & Co. Mr. Essner retired as Chairman and Chief Executive Officer of Wyeth Pharmaceuticals, Inc., now part of Pfizer Inc., in 2008. During his 32‑year career in the pharmaceutical industry, he held several prominent leadership positions, including Chairman of the Pharmaceutical Research and Manufacturers Association. Prior to Wyeth, Mr. Essner spent more than a decade in various management positions at Sandoz Pharmaceuticals Corporation and as President of Sandoz Consumer Healthcare Group. Mr. Essner was formerly a Director at MassMutual Financial Group. Mr. Essner is also an Executive-in-Residence and Adjunct Professor at Columbia Business School, where he teaches courses in healthcare management. He received a Bachelor’s degree from Miami University and a Master’s degree from the University of Chicago.

Mr. Essner serves as member of the Audit and Compliance Committee.

Back to Board of Directors